Barrington Research Predicts Reduced Earnings for Cinemark

Cinemark Holdings, Inc. (NYSE:CNKFree Report) – Research analysts at Barrington Research decreased their FY2025 earnings estimates for Cinemark in a research report issued on Monday, March 24th. Barrington Research analyst P. Sholl now forecasts that the company will post earnings of $1.29 per share for the year, down from their prior forecast of $1.38. Barrington Research currently has a “Outperform” rating and a $40.00 target price on the stock. The consensus estimate for Cinemark’s current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark’s FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.05 EPS.

Cinemark (NYSE:CNKGet Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.06). Cinemark had a net margin of 10.16% and a return on equity of 65.83%. The firm had revenue of $814.30 million during the quarter, compared to analyst estimates of $797.18 million. During the same period in the prior year, the company posted ($0.15) earnings per share. The firm’s revenue for the quarter was up 27.5% on a year-over-year basis.

CNK has been the topic of several other reports. Benchmark dropped their price objective on shares of Cinemark from $40.00 to $35.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Morgan Stanley lowered their price target on shares of Cinemark from $40.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Macquarie reaffirmed an “outperform” rating and set a $35.00 price target on shares of Cinemark in a research report on Thursday, February 20th. Wedbush restated a “neutral” rating and issued a $32.00 target price on shares of Cinemark in a research note on Tuesday, February 18th. Finally, Wells Fargo & Company reduced their price target on Cinemark from $38.00 to $36.00 and set an “overweight” rating for the company in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $32.70.

Check Out Our Latest Stock Analysis on Cinemark

Cinemark Price Performance

Shares of NYSE CNK opened at $25.66 on Wednesday. Cinemark has a 52 week low of $16.32 and a 52 week high of $36.28. The company has a quick ratio of 0.96, a current ratio of 1.01 and a debt-to-equity ratio of 3.28. The firm has a market cap of $3.14 billion, a P/E ratio of 12.64 and a beta of 2.41. The business’s 50 day moving average price is $27.74 and its 200 day moving average price is $29.47.

Institutional Investors Weigh In On Cinemark

Several institutional investors have recently bought and sold shares of CNK. Mackenzie Financial Corp purchased a new position in shares of Cinemark in the fourth quarter valued at approximately $221,000. Elequin Capital LP lifted its stake in shares of Cinemark by 211.6% in the fourth quarter. Elequin Capital LP now owns 997 shares of the company’s stock worth $31,000 after buying an additional 677 shares in the last quarter. PharVision Advisers LLC purchased a new position in Cinemark in the 4th quarter worth approximately $277,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Cinemark by 24.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 319,768 shares of the company’s stock worth $9,906,000 after buying an additional 61,911 shares in the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Cinemark during the fourth quarter worth $8,317,000.

Insider Transactions at Cinemark

In other news, insider Wanda Marie Gierhart sold 9,119 shares of the business’s stock in a transaction dated Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total transaction of $246,213.00. Following the completion of the sale, the insider now owns 147,414 shares of the company’s stock, valued at $3,980,178. The trade was a 5.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.30% of the company’s stock.

Cinemark Dividend Announcement

The firm also recently disclosed a — dividend, which was paid on Wednesday, March 19th. Stockholders of record on Wednesday, March 5th were given a $0.08 dividend. The ex-dividend date of this dividend was Wednesday, March 5th. Cinemark’s dividend payout ratio (DPR) is presently 15.76%.

About Cinemark

(Get Free Report)

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

Featured Stories

Earnings History and Estimates for Cinemark (NYSE:CNK)

Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.